Differential expression of suppressors of cytokine signaling-1 and -3 and related cytokines in central nervous system during remitting versus non-remitting forms of experimental autoimmune encephalomyelitis

International Immunology

Volumn 18, Issue 2, 2006, Pages 347-353

  Stark, Jennifer L ^a   Cross, Anne H ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cytokines; EAE; Multiple sclerosis; SOCS 1; SOCS 3

Indexed keywords

CELL PROTEIN; CILIARY NEUROTROPHIC FACTOR; CYTOKINE; FIBROBLAST GROWTH FACTOR 2; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 6; LEUKEMIA INHIBITORY FACTOR; MESSENGER RNA; SUPPRESSOR OF CYTOKINE SIGNALING 1; SUPPRESSOR OF CYTOKINE SIGNALING 3;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOREGULATION; CENTRAL NERVOUS SYSTEM DISEASE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HEMATOPOIETIC CELL; IMMUNOREGULATION; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; REMISSION; REMYELINIZATION; SPINAL CORD; TH1 CELL; TH2 CELL; UPREGULATION;

ANIMALS; CILIARY NEUROTROPHIC FACTOR; CYTOKINES; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; GROWTH SUBSTANCES; INTERLEUKIN-6; MICE; MICE, INBRED C57BL; MICE, INBRED STRAINS; SPINAL CORD; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; TH1 CELLS; TH2 CELLS;

EID: 31544435227     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxh373     Document Type: Article

References (32)

1. Lublin, F. D. and Reingold, S. C. 1996. Defining the clinical course of multiple sclerosis: Results of an international survey. Neurology 46:907.
2. Fritz, R. B., Chou, C.-H. J. and McFarlin, D. E. 1983. Relapsing murine experimental allergic encephalomyelitis induced by myelin basic protein. J. Immunol. 130:1024.
3. McRae, B. L., Kennedy, M. K., Tan, L.-J., Dal Canto, M. C., Picha, K. S. and Miller, S. D. 1992. Induction of active and adoptive relapsing experimental autoimmune encephalomyelitis (EAE) using an encephalitigenic epitope of proteolipid protein. J. Neuroimmunol. 38:229.
4. Slavin, A., Ewing, C., Liu, J., Ichikawa, M., Slavin, J. and Bernard, C. C. A. 1998. Induction of a multiple sclerosis-like disease in mice with an immunodominant epitope of myelin oligodendrocyte glycoprotein. Autoimmunity 28:109.
5. Endo, T. A., Masuhara, M., Yokouchi, M. et al. 1997. A new protein containing an SH2 domain that inhibits JAK kinases. Nature 387:921.
6. Alexander, W. S., Starr, R., Fenner, J. E. et al. 1999. SOCS1 is a critical inhibitor of interferon γ signaling and prevents the potentially fatal neonatal actions of this cytokine. Cell 98:597.
7. Lang, R., Pauleau, A.-L., Parganas, E. et al. 2003. SOCS3 regulates the plasticity of gp130 signaling. Nat. Immunol. 4:546.
8. Yasukawa, H., Ohishi, M., Mori, H. et al. 2003. IL-6 induces an anti-inflammatory response in the absence of SOCS3 in macrophages. Nat. Immunol. 4:551.
9. Egwuagu, C. E., Yu, C.-R., Zhang, M., Mahdi, R. M., Kim, S. J. and Gery, I. 2002. Suppressors of cytokine signaling proteins are differentially expressed in Th1 and Th2 cells: Implications for Th cell lineage commitment and maintenance. J. Immunol. 168:3181.
10. Shouda, T., Yoshida, T., Hanada, T. et al. 2001. Induction of the cytokine signal regulator SOCS3/CIS3 as a therapeutic strategy for treating inflammatory arthritis. J. Clin. Investig. 108:1781.
11. H2-mediated allergic responses. Nat. Med. 9:1047.
12. Wang, J. and Campbell, I. L. 2002. Cytokine signaling in the brain: putting a SOCS in it? J. Neurosci. Res. 67:423.
13. Albrecht, P. J., Murtie, J. C., Ness, J. K. et al. 2003. Astrocytes produce CNTF during the remyelination phase of viral-induced spinal cord demyelination to stimulate FGF-2 production. Neurobiol. Dis. 13:89.
14. Messersmith, D. J., Murtie, J. C., Le, T. Q., Frost, E. E. and Armstrong, R. C. 2000. Fibroblast growth factor 2 (FGF2) and FGF receptor expression in an experimental demyelinating disease with extensive remyelination. J. Neurosci. Res. 62:241.
15. Kennedy, M. K., Torrance, D. S., Picha, K. S. and Mohler, K. M. 1992. Analysis of cytokine mRNA expression in the central nervous system of mice with experimental autoimmune encephalomyelitis reveals that IL-10 mRNA expression correlates with recovery. J. Immunol. 149:2496.
16. Samoilova, E. B., Horton, J. L. and Chen, Y. 1998. Acceleration of experimental autoimmune encephalomyelitis in interleukin-10-deficient mice: Roles of interleukin-10 in disease progression and recovery. Cell. Immunol. 188:118.
17. McGeachy, M. J., Stephens, L. A. and Anderton, S. M. 2005. Natural recovery and protection from autoimmune encephalomyelitis: Contribution of CD4+CD25+ regulatory cells within the central nervous system. J. Immunol. 175:3025.
18. Maier, J., Kincaid, C., Pagenstecher, A. and Campbell, I. L. 2002. Regulation of signal transducer and activator of transcription and suppressor of cytokine-signaling gene expression in the brain of mice with astrocyte-targeted production of interleukin-12 or experimental autoimmune encephalomyelitis. Am. J. Pathol. 160:271.
19. Polizzotto, M. N., Bartlett, P. F. and Turnley, A. M. 2000. Expression of "suppressor of cytokine signalling" (SOCS) genes in the developing and adult nervous system. J. Comp. Neurol. 423:348.
20. Stark, J. L., Lyons, J.-A. and Cross, A. H. 2004. Interferon-gamma produced by encephalitogenic cells induces suppressors of cytokine signaling in primary murine astrocytes. J. Neuroimmunol. 151:195.
21. Donnelly, R. P., Dickensheets, H. and Finbloom, D. S. 1999. The interleukin-10 signal transduction pathway and regulation of gene expression in mononuclear phagocytes. J. Interferon Cytokine Res. 19:563.
22. Starr, R., Willson, T. A., Viney, E. M. et al, 1997. A family of cytokine-inducible inhibitors of signaling. Nature 387:917.
23. Mendel, I., Katz, A., Kozak, N., Ben-Nun, A. and Revel, M. 1998. Interleukin-6 functions in autoimmune encephalomyelitis: A study in gene-targeted mice. Eur. J. Immunol. 28:1727.
24. Samoilova, E. B., Horton, J. L., Hilliard, B., Liu., T.-S. T and Chen, Y. 1998. IL-6-deficient mice are resistant to experimental autoimmune encephalomyelitis: Roles of IL-6 in the activation and differentiation of autoreactive T cells. J. Immunol. 161:6480.
25. Okuda, Y., Sakoda, S., Saeki, Y., Kishimoto, T. and Yanagihara, T. 2000. Enhancement of Th2 response in IL-6-deficient mice immunized with myelin oligodendrocyte glycoprotein. J. Neuro-immunol. 105:120.
26. Linker, R. A., Maurer, M., Gaupp, S. et al. 2002. CNTF is a major protective factor in demyelinating CNS disease: A neurotrophic cytokine as modulator in neuroinflammation. Nat. Med. 8:620.
27. Butzkueven, H., Zhang, J.-G., Soilu-Hanninen, M. et al. 2002. LIF receptor signaling limits immune-mediated demyelination by enhancing oligodendrocyte survival. Nat. Med. 8:613.
28. Kerr, B. J. and Patterson, P. H. 2004. Potent pro-inflammatory actions of leukemia inhibitory factor in the spinal cord of the adult mouse. Exp. Neurol. 188:391.
29. Louis, J. C., Magal, E., Takayama, S. and Varon, S. 1993. CNTF protection of oligodendrocytes against natural and tumor necrosis factor-induced death. Science 259:689.
30. Stankoff, B., Aigrot, M.-S., Noel, F., Wattilliaux, A., Zalc, B. and Lubetzki, C. 2002. Ciliary neurotrophic factor (CNTF) enhances myelin formation: A novel role for CNTF and CNTF-related molecules. J. Neurosci. 22:9221.
31. Bansal, R. 2002. Fibroblast growth factors and their receptors in oligodendrocyte development: Implications for demyelination and remyelination. Dev. Neurosci. 24:35.
32. Ruffini, F., Furlan, R., Poliani, P. L. et al. 2001. Fibroblast growth factor-II gene therapy reverts the clinical course and the pathological signs of chronic experimental autoimmune encephalomyelitis in C57BL/6 mice. Gene Ther. 8:1207.